193 research outputs found

    Effect of sperm concentration and sperm ageing on fertilisation success in the Antarctic soft-shelled clam Laternula elliptica and the Antarctic limpet Nacella concinna

    No full text
    Sperm concentration and sperm ageing effects on fertilisation success were evaluated in the laboratory in the free-spawning Antarctic soft-shelled clam Laternula elliptica and Antarctic limpet Nacella concinna. Fertilisation success was highly dependent on sperm concentration. Highest levels of fertilisation success were consistently replicated at ~107 sperm ml-1 for L. elliptica, and ~106 to 108 sperm ml-1 for N. concinna. However, both species exhibited extremely low fertilisation rates at concentrations 106 sperm ml-1 N. concinna displayed a rapid increase in abnormally developing larvae which, along with only a small decline in total fertilisation success above 108 sperm ml-1, was taken to indicate polyspermy. A small increase in abnormal development followed by a rapid decline in fertilisation success at high sperm concentrations (>107 sperm ml-1) for L. elliptica was attributed to oxygen depletion. Using the optimum sperm concentration found for fertilisation success, spermatozoa were capable of fertilising fresh ova for >90 h in L. elliptica, and ~65 h in N. concinna. The sperm concentrations required for fertilisation success and sperm longevities reported here are at least an order of magnitude greater than those reported for nearshore temperate molluscs. Our data strongly suggest that the specific reproductive behaviour and timing of spawning activities displayed by these Antarctic molluscs is vital to enhance fertilisation success in the polar marine environment

    Effects of hydrostatic pressure on the magnetic susceptibility of ruthenium oxide Sr3Ru2O7: Evidence for pressure-enhanced antiferromagnetic instability

    Full text link
    Hydrostatic pressure effects on the temperature- and magnetic field dependencies of the in-plane and out-of-plane magnetization of the bi-layered perovskite Sr3Ru2O7 have been studied by SQUID magnetometer measurements under a hydrostatic helium-gas pressure. The anomalously enhanced low-temperature value of the paramagnetic susceptibility has been found to systematically decrease with increasing pressure. The effect is accompanied by an increase of the temperature Tmax of a pronounced peak of susceptibility. Thus, magnetization measurements under hydrostatic pressure reveal that the lattice contraction in the structure of Sr3Ru2O7 promotes antiferromagnetism and not ferromagnetism, contrary to the previous beliefs. The effects can be explained by the enhancement of the inter-bi-layer antiferromagnetic spin coupling, driven by the shortening of the superexchange path, and suppression, due to the band-broadening effect, of competing itinerant ferromagnetic correlations.Comment: 11 pages, 4 figure

    Spin-Peierls transition in NaV2O5 in high magnetic fields

    Get PDF
    We investigate the magnetic field dependence of the spin-Peierls transition in NaV2_2O5_5 in the field range 16T-30T. The transition temperature exhibits a very weak variation with the field, suggesting a novel mechanism for the formation of the spin-Peierls state. We argue that a charge ordering transition accompanied by singlet formation is consistent with our observations.Comment: 4 pages, 3 figures, final version to appear in Phys. Rev. B (RC

    A microscopic model for the structural transition and spin gap formation in alpha'-NaV2O5

    Full text link
    We present a microscopic model for alpha'-NaV2O5. Using an extended Hubbard model for the vanadium layers we derive an effective low-energy model consisting of pseudospin Ising chains and Heisenberg chains coupled to each other. We find a ``spin-Peierls-Ising'' phase transition which causes charge ordering on every second ladder and superexchange alternation on the other ladders. This transition can be identified with the first transition of the two closeby transitions observed in experiment. Due to charge ordering the effective coupling between the lattice and the superexchange is enhanced. This is demonstrated within a Slater-Koster approximation. It leads to a second instability with superexchange alternation on the charge-ordered ladders due to an alternating shift of the O sites on the rungs of that ladder. We can explain within our model the observed spin gap, the anomalous BCS ratio, and the anomalous shift of the critical temperature of the first transition in a magnetic field. To test the calculated superstructure we determine the low-energy magnon dispersion and find agreement with experiment.Comment: 32 pages, 12 figures include

    The role of sulfoglucuronosyl glycosphingolipids in the pathogenesis of monoclonal IgM paraproteinemia and peripheral neuropathy

    Get PDF
    In IgM paraproteinemia and peripheral neuropathy, IgM M-protein secretion by B cells leads to a T helper cell response, suggesting that it is antibody-mediated autoimmune disease involving carbohydrate epitopes in myelin sheaths. An immune response against sulfoglucuronosyl glycosphingolipids (SGGLs) is presumed to participate in demyelination or axonal degeneration in the peripheral nervous system (PNS). SGGLs contain a 3-sulfoglucuronic acid residue that interacts with anti-myelin-associated glycoprotein (MAG) and the monoclonal antibody anti-HNK-1. Immunization of animals with sulfoglucuronosyl paragloboside (SGPG) induced anti-SGPG antibodies and sensory neuropathy, which closely resembles the human disease. These animal models might help to understand the disease mechanism and lead to more specific therapeutic strategies. In an in vitro study, destruction or malfunction of the blood-nerve barrier (BNB) was found, resulting in the leakage of circulating antibodies into the PNS parenchyma, which may be considered as the initial key step for development of disease

    Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

    Get PDF
    This is the final version. Available on open access from Nature Research via the DOI in this recordData availability: The study protocol including the statistical analysis plan is available at https://www.clarityibd.org/. Individual participant de-identified data that underlie the results reported in this article will be available immediately after publication for a period of 5 years. Due to the sensitive nature of the data, this will be made available to investigators whose proposed use of the data has been approved by an independent review committee. Analyses will be restricted to the aims in the approved proposal. Proposals should be directed to [email protected]. To gain access data requestors will need to sign a data access agreement. Data from the Virus Watch study is currently being archived on the Office of National Statistics Secure Research Service and will be available shortly. Source data are provided with this paper in the Source Data file. Source data are provided with this paper.Code availability: Statistical analyses were undertaken in R 4.1.2 (R Foundation for Statistical Computing, Vienna, Austria. Code has been made available at: https://github.com/exeteribd/clarityibd-public.Anti tumour necrosis factor (anti-TNF) drugs increase the risk of serious respiratory infection and impair protective immunity following pneumococcal and influenza vaccination. Here we report SARS-CoV-2 vaccine-induced immune responses and breakthrough infections in patients with inflammatory bowel disease, who are treated either with the anti-TNF antibody, infliximab, or with vedolizumab targeting a gut-specific anti-integrin that does not impair systemic immunity. Geometric mean [SD] anti-S RBD antibody concentrations are lower and half-lives shorter in patients treated with infliximab than vedolizumab, following two doses of BNT162b2 (566.7 U/mL [6.2] vs 4555.3 U/mL [5.4], p <0.0001; 26.8 days [95% CI 26.2 - 27.5] vs 47.6 days [45.5 - 49.8], p <0.0001); similar results are also observed with ChAdOx1 nCoV-19 vaccination (184.7 U/mL [5.0] vs 784.0 U/mL [3.5], p <0.0001; 35.9 days [34.9 - 36.8] vs 58.0 days [55.0 - 61.3], p value < 0.0001). One fifth of patients fail to mount a T cell response in both treatment groups. Breakthrough SARS-CoV-2 infections are more frequent (5.8% (201/3441) vs 3.9% (66/1682), p = 0.0039) in patients treated with infliximab than vedolizumab, and the risk of breakthrough SARS-CoV-2 infection is predicted by peak anti-S RBD antibody concentration after two vaccine doses. Irrespective of the treatments, higher, more sustained antibody levels are observed in patients with a history of SARS-CoV-2 infection prior to vaccination. Our results thus suggest that adapted vaccination schedules may be required to induce immunity in at-risk, anti-TNF-treated patients
    corecore